Markets

Insider Trading

Hedge Funds

Retirement

Opinion

12 Most Advanced Countries in Biotechnology

In this article, we take a look at the 12 most advanced countries in biotechnology. You can skip our detailed analysis of the sector and go directly to 5 Most Advanced Countries in Biotechnology.

The Covid-19 pandemic has awoken the world to its vulnerability to airborne viruses whose outbreaks are extremely hard to contain. It certainly wasn’t the last pandemic, as a Nature study shows how loss of biodiversity is likely to increase the frequency of viral outbreaks. 

However, the pandemic was also an occasion that showcased the global biotechnological capability, as Covid vaccines were developed and rolled out within two years, allowing a return to normalcy.

How Big Data and AI are Transforming Biotechnology

Biotechnology, in comparison to many technological fields, is progressing rapidly. Thanks, in part, to AI. In many ways, the field’s progress has been massively boosted by Machine Learning (ML). For example, ML is increasingly being used for protein folding, an important step involved in drug discovery.

Recently, DeepMind, a UK-based AI subsidiary owned by Alphabet Inc. (NASDAQ:GOOG), announced its deep learning program called AlphaFold, which has solved 98.5% of human proteins’ structures. Prior to AlphaFold, the structure of only 17% of human proteins had been solved and it had been a challenge for half a century. 

Other Deep Learning techniques, such as image classification, are increasingly being adopted to detect cancer from medical scans among many other examples of AI in biotechnology. Deep Learning neural networks and big data have also proved to be highly effective in personalized medicine.

Benchsci, a provider of AI health technologies, has tracked the growth of biotechnology startups adopting Machine Learning technologies  and has shown that as of 2021, 230 biotechnology startups are using AI in the solutions they provide across the world. Some of the prominent startups in the industry include Ampilon, BioSymetrics, 3BIGS, BioRelate and Causaly. 

Big Players

Some of the top market players in the biotechnology industry include Eli Lilly and Company (NYSE:LLY), Novo Nordisk A/S (NYSE:NVO), Merck & Co., Inc. (NYSE:MRK), Pfizer Inc. (NYSE:PFE), BioNTech SE (NASDAQ:BNTX), argenx SE (NASDAQ:ARGX) and Galapagos NV (NASDAQ:GLPG).

Pfizer Inc. (NYSE:PFE), BioNTech SE (NASDAQ:BNTX) and Merck & Co., Inc. (NYSE:MRK) are known for significant contributions in helping solve recent disease outbreaks, with vaccines.

Other Biotechnology Trends to Watch in 2023

Another often overlooked but highly lucrative emerging field in biotechnology is the artificial meat industry. The meat and dairy industry’s carbon footprint is leading to a demand for artificial meat/dairy products. Its technology has been pioneered through stem cell research. Some leading US startups in this domain include Memphis Meats, New Age Meats and Finless Foods.

Industry Outlook: 2030

According to Grand View Research, the biotechnology industry is valued at $1 trillion as of 2021. The value is projected to reach nearly $4 trillion in 2030, with a CAGR of 14%

The cultured-meat sub-industry, on the other hand, is in its early phase and is valued at $600 million, going by their funding in 2020 and 2021. McKinsey estimates that the market value of lab-grown meat will reach $25 billion in 2030, as consumer acceptance gradually takes hold. Lab grown meat could account for 0.5% of the global meat supply by that time. 

Some of the top countries in terms of research in biotechnology include Singapore, Sweden, United States, United Kingdom and Germany. 

Below, we list the 12 most advanced countries in biotechnology.

Our Methodology

For our list of the 12 most advanced countries in biotechnology, we’ve ranked them based on a Nature study that evaluated the advancement of biotechnology in different countries based on important factors. 

The first factor was ‘public biotechnology’ that evaluated publicly listed biotech companies. Another pillar is focused on education and considers countries’ efforts in biotech fields in academia, like the number of degrees and students. The last pillar is centered around R&D investments in the biotechnology industry. 

To supplement our list of 12 most advanced countries in biotechnology, we’ve gathered the data from various other credible sources like Labio Tech and Tracxn for the number of companies and startups. 

Let’s dive in.

12. Austria

Number of Biotechnology Companies: 900+

Austria is located in the Southern zone of Central Europe. It is home to over 900 biotechnology companies. The country has over 2,400 researchers in the field working in 55 facilities and is home to 77,000 biotechnology students. 

According to Austrian Biotech, a go-to database for biotechnology in the country, 11.2% of the companies in the biotechnology sector are primarily involved in contract-based Research and Development. 

On the other hand, 22.5% are involved in Diagnostics and Analytical services. Another 27.4% are involved in Therapeutics. Some of the top biotechnology companies working on frontier biotechnologies include Phagomed, which develops viral treatments for bacterial infections and F2G, which develops novel treatments for fungal infections.

11. Germany

Number of Biotechnology Companies: 774+

Germany is one of the most advanced countries in biotechnology. It is overall a highly advanced nation in Europe. In terms of Knowledge-and-Technology-Intensive (KTI) industries, Germany contributed 6% to the overall global KTI output in 2019.

The number of biotechnology companies in the county has grown to over 774 as of 2021. As far as academia goes, there are 36 different biotechnology degrees offered in 33 universities in Germany, per Erudera.  

One of the most prominent biotechnology companies in Germany is BioNTech SE (NASDAQ:BNTX), which, as mentioned earlier, was involved in the development of the Pfizer-BioNTech vaccine for Covid-19, in collaboration with the American corporation Pfizer Inc. (NYSE:PFE).

10. Belgium

Number of Biotechnology Companies: 140+

Belgium is located in Northwestern Europe. It has over 140 biotechnology companies as of 2021, according to the leading Biotech news platform, Labio Tech. 

Belgian corporations account for almost 24% of the overall stock value of all biotechnology companies in Europe according to Flanders Investment and Trade. Its top players include argenx SE (NASDAQ:ARGX) and Galapagos NV (NASDAQ:GLPG).

9. Finland

Number of Biotechnology Companies: 120+

Finland is located in Northern Europe. It is one of the most advanced countries in terms of the biotechnology industry. According to rough estimates, the country is home to over 120 biotech companies as of 2021. 

Digital Health happens to be one of the fastest growing sub-industries within the broader sector. Its other strengths are in genomics and clinical analysis. It is largely thanks to the project FinnGen, a government funded project that was intended to obtain the genomic data of 500,000 citizens, 10% of the Finnish population. It is one of the most ambitious projects in the world.

8. Israel

Number of Biotechnology Companies: 160

Israel is located in the Middle East and is the most technologically advanced country in the region. It is home to 160 biotechnology companies as of 2021, according to Jewish Virtual Library. 

Some of the top startups in the country working in the industry include 1E Therapeutics, Future Meat and ReMilk. 1E Therapeutics is developing RNA-oriented treatments against various diseases. As of 2021, the startup has received $120 million in seed investments, as reported by Labio Tech. 

The other two — Future Meat and ReMilk — are working on developing lab meat and sustainable milk (using genetically modified yeast) respectively.

7. United Kingdom

Number of Biotechnology Companies: 415

The United Kingdom is the seventh on the list of most advanced countries in biotechnology. Around 415 Biotech companies are of British origin in Europe according to McKinsey. Between 2018-2020, 22 new biotechnology companies were founded in the country. 

It is one of the top three European countries with companies that are pursuing novel biotechnological solutions in areas like immunotherapy. Biotech startups in the country have an easier time securing early-stage funding than other countries in Europe but the UK lags behind China and the US in the average amount, by $25 million and $15 million, respectively. 

Some of the biotech startups to watch for in the country include Genomics, Healx and Bit Bio. Genomics is working in genomic-sequence analysis and interpretation and has secured $71 million in funding. Healx is another startup in the genomics domain, with $68 million in funding.  Bit Bio, on the other hand, is working in cell therapies and has $50 million in funding as of 2020. 

Apart from its own corporations and startups, the UK also hosts many global corporations like Merck & Co., Inc. (NYSE:MRK), Pfizer Inc. (NYSE:PFE), Eli Lilly and Company (NYSE:LLY), argenx SE (NASDAQ:ARGX), Novo Nordisk A/S (NYSE:NVO), BioNTech SE (NASDAQ:BNTX) and Galapagos NV (NASDAQ:GLPG).

6. Singapore

Number of Biotechnology Companies: 350+

Singapore is a city state located in Southeast Asia. The country is home to over 350 biotechnology companies as of 2022. Some top companies include Tessa Therapeutics, Biosensors and AUM Biosciences. 

However, they’re not quite as big in scale as global companies like Eli Lilly and Company (NYSE:LLY), Novo Nordisk A/S (NYSE:NVO), Merck & Co., Inc. (NYSE:MRK), Pfizer Inc. (NYSE:PFE), argenx SE (NASDAQ:ARGX), BioNTech SE (NASDAQ:BNTX) and Galapagos NV (NASDAQ:GLPG)

The top startups in Singapore include Holmusk, ETBio, CoFormula and Kinnva. Singapore’s biotech R&D is highly impactful, primarily due to its world-renowned high quality educational institutes. For a country with a population of only 5.4 million in 2021, Singapore received over 2,000 patent applications in the same year from its residents.

Click to continue reading and see 5 Most Advanced Countries in Biotechnology.

Suggested articles:

Disclosure: none. 12 Most Advanced Countries in Biotechnology is originally published on Insider Monkey.

AI Fire Sale: Insider Monkey’s #1 AI Stock Pick Is On A Steep Discount

Artificial intelligence is the greatest investment opportunity of our lifetime. The time to invest in groundbreaking AI is now, and this stock is a steal!

The whispers are turning into roars.

Artificial intelligence isn’t science fiction anymore.

It’s the revolution reshaping every industry on the planet.

From driverless cars to medical breakthroughs, AI is on the cusp of a global explosion, and savvy investors stand to reap the rewards.

Here’s why this is the prime moment to jump on the AI bandwagon:

Exponential Growth on the Horizon: Forget linear growth – AI is poised for a hockey stick trajectory.

Imagine every sector, from healthcare to finance, infused with superhuman intelligence.

We’re talking disease prediction, hyper-personalized marketing, and automated logistics that streamline everything.

This isn’t a maybe – it’s an inevitability.

Early investors will be the ones positioned to ride the wave of this technological tsunami.

Ground Floor Opportunity: Remember the early days of the internet?

Those who saw the potential of tech giants back then are sitting pretty today.

AI is at a similar inflection point.

We’re not talking about established players – we’re talking about nimble startups with groundbreaking ideas and the potential to become the next Google or Amazon.

This is your chance to get in before the rockets take off!

Disruption is the New Name of the Game: Let’s face it, complacency breeds stagnation.

AI is the ultimate disruptor, and it’s shaking the foundations of traditional industries.

The companies that embrace AI will thrive, while the dinosaurs clinging to outdated methods will be left in the dust.

As an investor, you want to be on the side of the winners, and AI is the winning ticket.

The Talent Pool is Overflowing: The world’s brightest minds are flocking to AI.

From computer scientists to mathematicians, the next generation of innovators is pouring its energy into this field.

This influx of talent guarantees a constant stream of groundbreaking ideas and rapid advancements.

By investing in AI, you’re essentially backing the future.

The future is powered by artificial intelligence, and the time to invest is NOW.

Don’t be a spectator in this technological revolution.

Dive into the AI gold rush and watch your portfolio soar alongside the brightest minds of our generation.

This isn’t just about making money – it’s about being part of the future.

So, buckle up and get ready for the ride of your investment life!

Act Now and Unlock a Potential 10,000% Return: This AI Stock is a Diamond in the Rough (But Our Help is Key!)

The AI revolution is upon us, and savvy investors stand to make a fortune.

But with so many choices, how do you find the hidden gem – the company poised for explosive growth?

That’s where our expertise comes in.

We’ve got the answer, but there’s a twist…

Imagine an AI company so groundbreaking, so far ahead of the curve, that even if its stock price quadrupled today, it would still be considered ridiculously cheap.

That’s the potential you’re looking at. This isn’t just about a decent return – we’re talking about a 10,000% gain over the next decade!

Our research team has identified a hidden gem – an AI company with cutting-edge technology, massive potential, and a current stock price that screams opportunity.

This company boasts the most advanced technology in the AI sector, putting them leagues ahead of competitors.

It’s like having a race car on a go-kart track.

They have a strong possibility of cornering entire markets, becoming the undisputed leader in their field.

Here’s the catch (it’s a good one): To uncover this sleeping giant, you’ll need our exclusive intel.

We want to make sure none of our valued readers miss out on this groundbreaking opportunity!

That’s why we’re slashing the price of our Premium Readership Newsletter by a whopping 70%.

For a ridiculously low price of just $29, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single restaurant meal!

Here’s why this is a deal you can’t afford to pass up:

• Access to our Detailed Report on this Game-Changing AI Stock: Our in-depth report dives deep into our #1 AI stock’s groundbreaking technology and massive growth potential.

• 11 New Issues of Our Premium Readership Newsletter: You will also receive 11 new issues and at least one new stock pick per month from our monthly newsletter’s portfolio over the next 12 months. These stocks are handpicked by our research director, Dr. Inan Dogan.

• One free upcoming issue of our 70+ page Quarterly Newsletter: A value of $149

• Bonus Reports: Premium access to members-only fund manager video interviews

• Ad-Free Browsing: Enjoy a year of investment research free from distracting banner and pop-up ads, allowing you to focus on uncovering the next big opportunity.

• 30-Day Money-Back Guarantee:  If you’re not absolutely satisfied with our service, we’ll provide a full refund within 30 days, no questions asked.

 

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $29.

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!


No worries about auto-renewals! Our 30-Day Money-Back Guarantee applies whether you’re joining us for the first time or renewing your subscription a year later!

A New Dawn is Coming to U.S. Stocks

I work for one of the largest independent financial publishers in the world – representing over 1 million people in 148 countries.

We’re independently funding today’s broadcast to address something on the mind of every investor in America right now…

Should I put my money in Artificial Intelligence?

Here to answer that for us… and give away his No. 1 free AI recommendation… is 50-year Wall Street titan, Marc Chaikin.

Marc’s been a trader, stockbroker, and analyst. He was the head of the options department at a major brokerage firm and is a sought-after expert for CNBC, Fox Business, Barron’s, and Yahoo! Finance…

But what Marc’s most known for is his award-winning stock-rating system. Which determines whether a stock could shoot sky-high in the next three to six months… or come crashing down.

That’s why Marc’s work appears in every Bloomberg and Reuters terminal on the planet…

And is still used by hundreds of banks, hedge funds, and brokerages to track the billions of dollars flowing in and out of stocks each day.

He’s used this system to survive nine bear markets… create three new indices for the Nasdaq… and even predict the brutal bear market of 2022, 90 days in advance.

Click to continue reading…